These dissimilarities could be due to the inclusion in the study by (24) of only obese children, and some of them with type 2 diabetes on insulin or metformin treatment which might interfere with triglyceride, glucose, and insulin metabolism. The gene discussed is INS; the disease is type 2 diabetes mellitus.